Phase 2 validation of AFP, DCP and AFP-L3 in early stage hepatocellular carcinoma

被引：0
|
作者：
Marrero, Jorge A.
Llovet, Josep M.
Nguyen, Mindie
Befeler, Alex
Roberts, Lewis R.
Reddy, Rajender R.
Harnois, Denise
Normolle, Daniel
Hui, Ying
Dalhgren, Jackie
Chia, David
Lok, Anna S.
Wagner, Paul D.
Feng, Ziding
Schwartz, Myron
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Mt Sinai Univ, New York, NY USA
[3] Stanford Univ, Palo Alto, CA 94304 USA
[4] Mayo Clin, Rochester, MN USA
[5] Univ Penn, Mayo Clin, Jacksonville, FL USA
[6] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[7] NCI, Bethesda, MD 20892 USA
来源：
CANCER BIOMARKERS | 2008年 / 4卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：183 / 183
页数：1
相关论文
共 50 条
  • [41] THE PERFORMANCE OF AFP, AFP-3, DCP AS BIOMARKERS FOR DETECTION OF HEPATOCELLULAR CARCINOMA (HCC). A PHASE 3 BIOMARKER STUDY IN THE UNITED STATES
    Tayob, Nabihah
    Kanwal, Fasiha
    Alsarraj, Abeer
    Hernaez, Ruben
    El-Serag, Hashem B.
    HEPATOLOGY, 2021, 74 : 107A - 108A
  • [42] The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States
    Tayob, Nabihah
    Kanwal, Fasiha
    Alsarraj, Abeer
    Hernaez, Ruben
    El-Serag, Hashem B.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (02) : 415 - 423.e4
  • [43] Identification of Plasma hsa_circ_0005397 and Combined With Serum AFP, AFP-L3 as Potential Biomarkers for Hepatocellular Carcinoma
    Liu, Ruoyu
    Li, Yi
    Wu, Anqi
    Kong, Mingzhu
    Ding, Weijia
    Hu, Zeyang
    Chen, Lin
    Cai, Weihua
    Wang, Feng
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [44] Combination of AFP, AFP-l3 and PIVKA-II levels improves diagnostic accuracy of hepatocellular carcinoma (ALPS score)
    Lee, Han Ah
    Kim, Tae Hyung
    Lee, Young-Sun
    Jung, Young Kul
    Kim, Ji Hoon
    Yim, Hyung Joon
    Yeon, Jong Eun
    Byun, Kwan Soo
    Um, Soon Ho
    Seo, Yeon Seok
    JOURNAL OF HEPATOLOGY, 2020, 73 : S371 - S371
  • [45] SENSITIVITY AND SPECIFICITY OF ALPHA-FETO PROTEIN (AFP), LENS CULINARIS AGGLUTININ-REACTIVE AFP (AFP-L3) AND DES-GAMMA-CARBOXYPROTHROMBIN (DCP) AS TUMOR MARKERS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)
    Ertle, J. M.
    Wichert, M.
    Kueper, R.
    Hilgard, P.
    Gerken, G.
    Schlaak, J.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S384 - S384
  • [46] DCP和AFP-L3在AFP低浓度原发性肝癌诊断中的意义
    庄国华
    李宏
    杨学军
    金小仙
    中国卫生检验杂志, 2014, 24 (17) : 2538 - 2540
  • [47] DCP、AFP-L3和AFP在原发性肝细胞癌诊断中的价值
    付水
    齐娟飞
    朱海燕
    祁志荣
    陈红艳
    放射免疫学杂志, 2013, 26 (01) : 75 - 78
  • [48] THE PERFORMANCE OF TRIPLE BIOMARKERS (AFP, AFP-3, DCP) FOR EARLY DETECTION OF HEPATOCELLULAR CARCINOMA (HCC). A PROSPECTIVE COHORT PHASE 3 BIOMARKER STUDY IN THE UNITED STATES
    El-Serag, Hashem B.
    Tayob, Nabihah
    Kanwal, Fasiha
    Alsarraj, Abeer
    Hernaez, Ruben
    GASTROENTEROLOGY, 2019, 156 (06) : S1309 - S1310
  • [49] Alpha-Fetoprotein (AFP) and AFP-L3 Is Most Useful in Detection of Recurrence of Hepatocellular Carcinoma in Patients after Tumor Ablation and with Low AFP Level
    Force, Madison
    Park, Grace
    Chalikonda, Divya
    Roth, Christopher
    Cohen, Micah
    Halegoua-DeMarzio, Dina
    Hann, Hie-Won
    VIRUSES-BASEL, 2022, 14 (04):
  • [50] 联合血清AFP-L3%和DCP在AFP低水平HCC诊断中的作用
    杨术生
    方欢英
    检验医学与临床, 2022, 19 (01) : 51 - 54
12345